拜耳在新生物领域的 AI 在欧洲获得批准

拜耳作物科学表示,其正在等待在欧洲上市的生物杀虫剂 Requiem 的活性成分 Terpenoid Blend QRD 460 最近已获得欧盟委员会的批准。

安魂曲可以控制刺吸式害虫并提高收获农产品的质量。 Requiem 预计在 2016 年底前在一些欧洲国家进行首次注册。计划于 2017 年在欧洲上市。

“Requiem is the latest innovation from Bayer CropScience in the field of biological insecticides and an important addition to integrated pest management (IPM) programs in greenhouse vegetables,” said Gilles Chevallier, Global Product Management Biological Insecticides at Bayer CropScience. “Its mode of action is effective against sucking pests, especially thrips, whiteflies, aphids and mites, leading to healthier crops and better-quality produce.”

“We are very proud of the approval by the European Commission,” said Nick Wright, Global Regulatory Manager Biologicals at Bayer CropScience. “This is the first time a Bayer active substance gains approval under the new EU regulation 1107/2009.” The regulation was designed to ensure high level of protection of both human and animal health and the environment; while improving agricultural production. “The harmonization for the authorization of plant protection products within the EU will help us providing growers across Europe innovative tools like Requiem,” Wright added.

根据拜耳的说法,安魂曲的开发是为了控制各种水果和蔬菜以及一些中耕作物中的刺吸式害虫。 Requiem 旨在用作叶面杀虫剂和杀螨剂——在喷雾程序中,作为独立的或与化学作物保护产品一起使用。除了其功效水平外,该产品还为种植者提供灵活的使用率和灵活的应用时间。它不受最大残留水平 (MRL) 限制,兼容 IPM,具有较短的再进入间隔,并且没有收获前间隔。此外,它还是阻力管理的宝贵工具。

拜耳表示,Requiem 是基于萜烯的优化混合物,旨在模拟天然存在的植物 Chenopodium ambrosioides 附近 ambrosioides 的提取物,这是一种开花植物,通常被称为 Epazote 和 American Wormseed。拜耳表示,它能够让这种混合物作为单一活性物质在美国和欧盟成功获得批准。